SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061101
Filing Date
2023-11-08
Accepted
2023-11-08 16:09:25
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20231108.htm   iXBRL 8-K 54398
2 EX-99.1 srzn-ex99_1.htm EX-99.1 252933
  Complete submission text file 0000950170-23-061101.txt   475313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srzn-20231108_pre.xml EX-101.PRE 12994
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srzn-20231108_def.xml EX-101.DEF 13694
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srzn-20231108_lab.xml EX-101.LAB 17592
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srzn-20231108.xsd EX-101.SCH 3109
8 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20231108_htm.xml XML 6585
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 231387896
SIC: 2836 Biological Products, (No Diagnostic Substances)